Meet the 2022 Lymphoma Scientific Research Mentoring Program Scholars
The Lymphoma Research Foundation’s (LRF) Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma and CLL research, whether in the lab or in the clinic.
The primary goal of the LSRMP is to retain its talented participants — called LRF Scholars — in the field of lymphoma by providing mentoring and education programming and fostering research collaboration among expert faculty and grantees.
Led by the 2022 LSRMP Clinical Research co-chairs, Steven Horwitz, MD (Memorial Sloan Kettering Cancer Center) and Kami Maddocks, MD (The Ohio State University Comprehensive Cancer Center), and Laboratory/Translational Research co-chairs, Ari Melnick, MD (Weill Cornell Medicine) Christian Steidl, MD (BC Cancer, Vancouver), and Laura Pasqualucci, MD (Columbia University), the new class is boasting translational and clinical researchers pursuing a diverse range of research projects with a goal to improve patient outcomes.
Clinical Research LRF Scholars
Dai Chihara, MD
University of Texas MD Anderson Cancer Center
Research Study: Informing Phase 1 Trial Designs in Lymphoma
Lymphoma Focus: Non-Hodgkin lymphoma
Read full Researcher Spotlight >
Paola Ghione, MD
Memorial Sloan Kettering Cancer Center
Research Study: A phase I-II study of parsaclisib and ruxolitinib for Rel/Refr T/NK cell lymphoma
Lymphoma Focus: Aggressive T-cell lymphomas
Read full Researcher Spotlight >
David Qualls, MD
Memorial Sloan Kettering Cancer Center
Research Study: Combination Epcoritamab and GEN1046 in Relapsed or Refractory Follicular Lymphoma
Lymphoma Focus: Indolent Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma
Read full Researcher Spotlight >
Helen Ma, MD
Stephanie A. Gregory Distinguished Scholar
The Regents of the University of California
Research Study: Outcomes of Exposure-Related Lymphoid Malignancies Compared to Unexposed Matched Controls at the VA
Lymphoma Focus: B-cell lymphomas
Read full Researcher Spotlight >
Harsh Shah, DO
The University of Utah
Stephen Family Scholar
Research Study: Anti-PD-1 and anti-CSF1-R blockade in patients with relapsed/refractory classical Hodgkin Lymphoma
Lymphoma Focus: Hodgkin Lymphomas
Read full Researcher Spotlight >
Samuel Yamshon, MD
Joan & Sanford I. Weill Medical College of Cornell University
Research Study: A Phase Ib Trial of Tazemetostat plus Mosunetuzumab in Untreated Follicular Lymphoma
Lymphoma Focus: Indolent Lymphomas, Follicular Lymphoma
Read full Researcher Spotlight >
Laboratory/Translational Research LRF Scholars
Ohwhofasa Agbedia, MBBS, MPH
University of Texas MD Anderson Cancer Center Research Study: Targeting aggressive CD94-expressing NK/T-cell lymphoproliferative disorders with CAR T-cell therapy
Lymphoma Focus: T-cell lymphoma, aggressive lymphomas
Read full Researcher Spotlight >
Robert Albero Gallego, PhD
Columbia University
Research Study: Identifying epigenetic vulnerabilities in Peripheral T-cell Lymphomas
Lymphoma Focus: T-cell lymphoma
Read full Researcher Spotlight >
Tayla Foral, PhD
Dana-Farber Cancer Institute
Research Study: Defining Vulnerabilities in T-cell Lymphoma Via Nascent Transcriptomic Profiling
Lymphoma Focus: T-cell lymphoma
Read full Researcher Spotlight >
Matthew Klairmont, MD
New York University School of Medicine
Research Study: The role of lymph node stromal cells in follicular lymphoma
Lymphoma Focus: Follicular lymphoma
Read full Researcher Spotlight >
Patrick Reville, MD
The University of Texas, M.D. Anderson Cancer Center
Research Study: CD38 as a Targetable Antigen in Large B Cell Lymphoma Combined with CD19 CAR T Cells
Lymphoma Focus: B-cell lymphomas
Read full Researcher Spotlight >
Laurianne Scourzic, PhD
Joan & Sanford I. Weill Medical College of Cornell University
Research Study: Characterizing the lymphoma repopulating potential of stem-like GC B-cell subpopulations
Lymphoma Focus: B-cell lymphomas
Read full Researcher Spotlight >
Impact on Research
The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma. LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.